The neuroprotection for photoreceptor apoptosis via selective antagonist, BBG
| Project/Area Number |
23791991
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Ophthalmology
|
|---|
| Research Institution | 国立病院機構九州医療センター (2012)
National Hospital Organization, Kyushu Medical Center (Clinical Institute) (2011) |
|---|
Principal Investigator |
HISATOMI Toshio 国立病院機構九州医療センター, 眼科, 科長 (50404033)
|
|---|
| Project Period (FY) |
2011 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2012: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2011: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
|
|---|
| Keywords | 眼細胞生物学 |
|---|
| Research Abstract |
The retinal cells developed apoptosis via P2X7 receptor dependent pathways. Cell death developed via rapid Ca++ intake into the cells and followed by apoptotic molecular signals such as membrane permeabilization, caspase activation, cytochrome c and AIF translocation. P2X7 receptor knockout mice showed decreased cell death without P2X7 receptor. The cell death and following molecular signal transduction were reversed by selective antagonist, BBG.
|
Report
(3 results)
Research Products
(16 results)
